NSE2 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-NSE2 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | NSE2 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) Paraffin, ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: NSE2 Polyclonal Antibody detects endogenous levels of NSE2 protein. FAM84B (family with sequence similarity 84, member B), also known as NSE2 or BCMP101, is a 310 amino acid protein that is expressed in esophageal squamous cell carcinomas, suggesting a role in tumor development and metastasis. The gene encoding FAM84B maps to human chromosome 8, which consists of nearly 146 million base pairs, houses more than 800 genes and is associated with a variety of diseases and malignancies. Schizophrenia, bipolar disorder, trisomy 8, Pfeiffer syndrome, congenital hypothyroidism, Waardenburg syndrome and some leukemias and lymphomas are thought to occur as a result of defects in specific genes that map to chromosome 8. |
| Immunogen | Immunogen: Synthesized peptide derived from the N-terminal region of human NSE2 at AA rangle: 30-110 |
| Other Names | [Rabbit NSE2; FAM84B; BCMP101; NSE2; Protein FAM84B; Breast cancer membrane protein 101; Protein NSE2] |
| Gene, Accession # | [NSE2], Gene ID: 157638, NCBI: NP_777571.1, UniProt: Q96KN1 |
| Catalog # | MBS9704588 |
| Price | $130, $220, $325 |
| Order / More Info | NSE2 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies